KMTS Market Analysis
Wall Street coverage
third-party contextWall Street coverage
$30.00median target· current $22.83 (+31.4%)7 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio—
EPS (TTM)$-2.430.0% YoY
Profit margin-138.3%HEALTHCARE
Market cap$1.34BSmall cap
Valuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- 5.16
- P/S (TTM)
- 14.06
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- -56.6%
- Operating margin
- -137.4%
- Revenue growth YoY
- 66.2%
- Dividend yield
- —
- Beta
- —
Last earnings
Jul 14, 2026 · Estimate $-0.59 · Reported $-0.67
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Kestra Medical Technologies, Ltd. Common Stock
Company profileKestra Medical Technologies, Ltd. is a wearable medical device and digital healthcare company. The company is headquartered in Kirkland, Washington.
Classification
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 3933 LAKE WASHINGTON BLVD NE, KIRKLAND, WA
- Fiscal year end
- April
- Latest quarter
- Apr 30, 2026
Market cap$1.34B
Shares outstanding$58.6M
52W high$30.00
52W low$14.10
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent